Benzodiazepine use during buprenorphine treatment for opioid dependence: Clinical and safety outcomes

被引:51
|
作者
Schuman-Olivier, Zey [1 ,2 ]
Hoeppner, Bettina B. [1 ,2 ]
Weiss, Roger D. [1 ,4 ]
Borodovsky, Jacob [3 ]
Shaffer, Howard J. [1 ]
Albanese, Mark J. [1 ]
机构
[1] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Tufts Univ, Boston, MA 02111 USA
[4] McLean Hosp, Belmont, MA 02178 USA
关键词
Buprenorphine; Opioid dependence; Benzodiazepine; Accident; Female; Utilization; METHADONE-MAINTENANCE TREATMENT; GENDER-DIFFERENCES; PRIMARY-CARE; ABUSE; SUBSTITUTION; MORTALITY; DRUGS; PHARMACOKINETICS; TRANQUILIZERS; IMPAIRMENT;
D O I
10.1016/j.drugalcdep.2013.04.006
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Prescribing benzodiazepines during buprenorphine treatment is a topic of active discussion. Clinical benefit is unclear. Overdose, accidental injury, and benzodiazepine misuse remain concerns. We examine the relationship between benzodiazepine misuse history, benzodiazepine prescription, and both clinical and safety outcomes during buprenorphine treatment. Methods: We retrospectively examined outpatient buprenorphine treatment records, classifying patients by past-year benzodiazepine misuse history and approved benzodiazepine prescription at intake. Primary clinical outcomes included 12-month treatment retention and urine toxicology for illicit opioids. Primary safety outcomes included total emergency department (ED) visits and odds of an ED visit related to overdose or accidental injury during treatment. Results: The 12-month treatment retention rate for the sample (N = 328) was 40%. Neither benzodiazepine misuse history nor benzodiazepine prescription was associated with treatment retention or illicit opioid use. Poisson regressions of ED visits during buprenorphine treatment revealed more ED visits among those with a benzodiazepine prescription versus those without (p < 0.001); benzodiazepine misuse history had no effect. The odds of an accidental injury-related ED visit during treatment were greater among those with a benzodiazepine prescription (OR: 3.7, p < 0.01), with an enhanced effect among females (OR: 4.7, p < 0.01). Overdose was not associated with benzodiazepine misuse history or prescription. Conclusions: We found no effect of benzodiazepine prescriptions on opioid treatment outcomes; however, benzodiazepine prescription was associated with more frequent ED visits and accidental injuries, especially among females. When prescribing benzodiazepines during buprenorphine treatment, patients need more education about accidental injury risk. Alternative treatments for anxiety should be considered when possible, especially among females. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:580 / 586
页数:7
相关论文
共 50 条
  • [41] Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine A Randomized Clinical Trial
    Rosenthal, Richard N.
    Lofwall, Michelle R.
    Kim, Sonnie
    Chen, Michael
    Beebe, Katherine L.
    Vocci, Frank J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (03): : 282 - 290
  • [42] Clinical case discussion: Treating opioid dependence with buprenorphine
    Alford, Daniel P.
    Salsitz, Edwin A.
    Martin, Judith
    Renner, John A.
    [J]. JOURNAL OF ADDICTION MEDICINE, 2007, 1 (02) : 73 - 78
  • [43] The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone
    Stein, Bradley D.
    Gordon, Adam J.
    Sorbero, Mark
    Dick, Andrew W.
    Schuster, James
    Farmer, Carrie
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2012, 123 (1-3) : 72 - 78
  • [44] The promise and challenges of buprenorphine implant for treatment of opioid dependence
    Basu, Debasish
    Sahoo, Swapnajeet
    Ghosh, Abhishek
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2017, 30 (02): : 80 - 81
  • [45] Buprenorphine: a potential new treatment option for opioid dependence
    Srivastava, Anita
    Kahan, Meldon
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (13) : 1835 - 1836
  • [46] Buprenorphine vs methadone maintenance treatment for opioid dependence
    Fischer, G
    Gombas, W
    Eder, H
    Jagsch, R
    Stühlinger, G
    Aschauer, HN
    Kasper, S
    [J]. NERVENARZT, 1999, 70 (09): : 795 - 802
  • [47] Buprenorphine versus methadone maintenance for the treatment of opioid dependence
    Fischer, G
    Gombas, W
    Eder, H
    Jagsch, R
    Peternell, A
    Stühlinger, G
    Pezawas, L
    Aschauer, HN
    Kasper, S
    [J]. ADDICTION, 1999, 94 (09) : 1337 - 1347
  • [48] Implantable Buprenorphine (Probuphine) for Maintenance Treatment of Opioid Dependence
    Goodbar, Nancy Hope
    Hanlon, Katherine E.
    [J]. AMERICAN FAMILY PHYSICIAN, 2018, 97 (10) : 668 - 670
  • [49] Comparison of Buprenorphine Treatment for Opioid Dependence in 3 Settings
    Miotto, Karen
    Hillhouse, Maureen
    Donovick, Roger
    Cunningham-Rathner, Jerry
    Charuvastra, Charlie
    Torrington, Matthew
    Esagoff, Asher E.
    Ling, Walter
    [J]. JOURNAL OF ADDICTION MEDICINE, 2012, 6 (01) : 68 - 76
  • [50] Buprenorphine oral lyophilisate (Espranor®) in the substitution treatment of opioid dependence: a profile of its use
    Lyseng-Williamson K.A.
    [J]. Drugs & Therapy Perspectives, 2017, 33 (6) : 241 - 248